Metabolic associations with genes known to associate with bladder cancer (BLCAP), ovarian cancer (OCIAD1), and infertility caused by azoospermia (DAZAP1) could highlight the importance of integrating both methylation and metabolomics for assessing T2D complications. Here, BLCAP is linked to type 2 diabetes mellitus.